Newer monoclonal antibody approved for rheumatoid ahritis is:: (A) Durvalumab, (B) Pembrolizumab, (C) Nivolumab, (D) Sarilumab
Answer is D. Sarilumab: Monoclonal antibody against IL6, used for rheumatoid ahritis. Six - SARILUMAB - monoclonal antibody | Interleukin Durvalumab: Monoclonal antibody for urothelial carcinoma. DURVALUMAB - Urothelial Ca Nivolumab/Sarilumab: Monoclonal antibody for non small cell lung cancer(NSCLC). Durvalumab, Nivolumab, Sarilumab: Target program death ligand of T cell. T cell get activated and kills cancer cells.